Viewing Study NCT02217904


Ignite Creation Date: 2025-12-24 @ 7:50 PM
Ignite Modification Date: 2025-12-31 @ 9:59 AM
Study NCT ID: NCT02217904
Status: COMPLETED
Last Update Posted: 2019-08-12
First Post: 2014-08-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Islatravir (MK-8591) in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus-1 Infected Participants (MK-8591-003)
Sponsor: Merck Sharp & Dohme LLC
Organization: